Drug Insight: prolactin-receptor antagonists, a novel approach to treatment of unresolved systemic and local hyperprolactinemia? | Nature Reviews Endocrinology
Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and without Cocaine Dependence | Neuropsychopharmacology
a Acute alcohol withdrawal resulted in an increase of plasma prolactin... | Download Scientific Diagram
Characterization of Pyrrolidinyl-hexahydro-pyranopiperazines as a Novel Kappa Opioid Receptor Agonist Scaffold | ACS Chemical Neuroscience
Antagonists of the kappa opioid receptor. | Semantic Scholar
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
Alleviation of Cocaine Withdrawal and Pertinent Interactions between Salvinorin-Based Antagonists and Kappa Opioid Receptor | ACS Chemical Neuroscience
Frontiers | Opioid Receptor-Mediated Regulation of Neurotransmission in the Brain
Kappa Opioid Receptor Antagonists as Potential Therapeutics for Mood and Substance Use Disorders | SpringerLink
Opioid Receptor Subtypes Involved in the Regulation of Prolactin Secretion During Pregnancy and Lactation - Andrews - 2003 - Journal of Neuroendocrinology - Wiley Online Library
Antagonists of the kappa opioid receptor. | Semantic Scholar
Pleiotropic Effects of Kappa Opioid Receptor-Related Ligands in Non-human Primates. - Abstract - Europe PMC
Preclinical evaluation of the kappa-opioid receptor antagonist CERC-501 as a candidate therapeutic for alcohol use disorders | Neuropsychopharmacology
Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and without Cocaine Dependence | Neuropsychopharmacology
Opioid Receptor Subtypes Involved in the Regulation of Prolactin Secretion During Pregnancy and Lactation - Andrews - 2003 - Journal of Neuroendocrinology - Wiley Online Library
Nalmefene Induced Elevation in Serum Prolactin in Normal Human Volunteers: Partial Kappa Opioid Agonist Activity? | Neuropsychopharmacology
Dynorphin A1–13 Causes Elevation of Serum Levels of Prolactin Through an Opioid Receptor Mechanism in Humans: Gender Differences and Implications for Modulation of Dopaminergic Tone in the Treatment of Addictions | Journal
a) Mean ( 7 SEM) level of serum prolactin at each time point from 0 to... | Download Scientific Diagram
Antagonists of the kappa opioid receptor - ScienceDirect
Alleviation of Cocaine Withdrawal and Pertinent Interactions between Salvinorin-Based Antagonists and Kappa Opioid Receptor | ACS Chemical Neuroscience
Summary of select antipsychotic drugs on prolactin levels | Download Table
Kappa Opioid Receptor Antagonists as Potential Therapeutics for Mood and Substance Use Disorders | SpringerLink
Design and Synthesis of a Novel and Selective Kappa Opioid Receptor (KOR) Antagonist (BTRX-335140) | Journal of Medicinal Chemistry
